The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience ...

Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The Food and Drug Administration granted Expanded Access Program authorization for NKGen's investigational drug application.

Sarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

A Biotech Factory Rises in the Southland. By Denise Gellene . June 20, 2004 12 AM PT . ... When Biogen Idec Inc.’s $380-million pharmaceutical factory being built there opens in 2005, ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. The ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...